Drug-induced valvular heart disease: An update

被引：33
|
作者：
Andrejak, Michel [1 ,2 ]
Tribouilloy, Christophe [2 ,3 ]
机构：
[1] CHU Amiens, Hop Sud, Serv Pharmacol Clin, F-80054 Amiens 1, France
[2] INSERM, U1088, Amiens, France
[3] CHU Amiens, Serv Cardiol, Amiens, France
来源：
ARCHIVES OF CARDIOVASCULAR DISEASES | 2013年 / 106卷 / 05期
关键词：
Drug induced valvular disease; Ergot alkaloids; Ergot-derived dopamine agonists; Norfenfluramine; Valvular regurgitation; APPETITE-SUPPRESSANT DRUGS; CARDIAC-VALVE REGURGITATION; PARKINSONS-DISEASE; BENFLUOREX THERAPY; DOPAMINE AGONISTS; TRICUSPID REGURGITATION; METHYSERGIDE THERAPY; INDUCED VALVULOPATHY; DIABETES-MELLITUS; FENFLURAMINE;
D O I：
10.1016/j.acvd.2013.02.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Numerous reports have shown an unquestionable association between fibrotic valve disease and the following drugs: ergot alkaloids (such as methysergide and ergotamine), ergot-derived dopaminergic agonists (such as pergolide and cabergoline) and drugs metabolized into norfenfluramine (such as fenfluramine, dexfenfluramine and benfluorex). This review focuses on different aspects of drug-induced valvular heart disease: historical background; echocardiographic features; different drugs recognized as being responsible for valvular heart disease; and pathophysiology. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：333 / 339
页数：7
相关论文
共 50 条
  • [31] Drug-induced lupus: an update
    Vasoo, S.
    LUPUS, 2006, 15 (11) : 757 - 761
  • [32] In vivo model of drug induced valvular heart disease in rats: pergolide induced valvular heart disease demonstrated with echocardiography and correlation with pathology
    Droogmans, S.
    Franken, P. R.
    Weytjens, C.
    Cosyns, B.
    Lahoutte, T.
    Caveliers, V.
    Bossuyt, A.
    Schoors, D.
    Van Camp, G.
    EUROPEAN HEART JOURNAL, 2007, 28 : 655 - 655
  • [33] Pregnancy Complicated by Valvular Heart Disease: An Update
    Nanna, Michael
    Stergiopoulos, Kathleen
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (03):
  • [34] New series - Valvular heart disease update
    Griffin, BP
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (10) : 880 - 880
  • [35] Update on Valvular Heart Disease for Registered Nurses
    Wyman, Janet F.
    Cusin, Crystal
    Gjurovski, Dayna
    NURSING CLINICS OF NORTH AMERICA, 2023, 58 (03) : 357 - 378
  • [36] PERSPECTIVE ON VALVULAR HEART-DISEASE - AN UPDATE
    RAHIMTOOLA, SH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (01) : 1 - 23
  • [37] Update in the clinical management of valvular heart disease
    Akhter, Mohammed W.
    Rahimtoola, Shahbudin H.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (04): : 333 - 341
  • [38] Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study
    Marechaux, Sylvestre
    Rusinaru, Dan
    Jobic, Yannick
    Ederhy, Stephane
    Donal, Erwan
    Reant, Patricia
    Arnalsteen, Elise
    Boulanger, Jacques
    Garban, Thierry
    Ennezat, Pierre-Vladimir
    Jeu, Antoine
    Szymanski, Catherine
    Tribouilloy, Christophe
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2015, 16 (02) : 158 - 165
  • [39] DRUG-INDUCED DISEASES - DRUG-INDUCED METABOLIC DISEASE
    RICHARDS, P
    BRITISH MEDICAL JOURNAL, 1979, 1 (6171): : 1128 - 1129
  • [40] DRUG-INDUCED DISEASES - DRUG-INDUCED HEMATOLOGICAL DISEASE
    DAWSON, AA
    BRITISH MEDICAL JOURNAL, 1979, 1 (6172): : 1195 - 1197
12345